AGT and esophageal squamous cell carcinoma: We also found that mTOR expression was increased in ESCC cells under angiotensin II stimulation in a dose-dependent manner, and that the angiotensin II-enhanced growth capability of ESCC cells was reduced in cells treated with mTOR inhibitors.